bell
The current prices are delayed by 15 mins, login to check live prices.
Aarti Pharmalabs Ltd share price logo

Aarti Pharmalabs Ltd

(AARTIPHARM)

₹585.051.11%

as on 04:01PM, 24 Dec 2024

Overview
News
Financials
Q2 2024 Results
Technicals

Aarti Pharmalabs Ltd Performance

  • Day's Low

    Day's High

    ₹571.5
    Day's Price Range
    ₹589.9
  • 52 Week's Low

    52 Week's High

    ₹399.55
    52-Week Price Range
    ₹721.7
1 Month Return-7.97 %
3 Month Return-6.13 %
1 Year Return+ 15.74 %
Previous Close₹578.65
Open₹573.15
Volume96.84K
Upper Circuit-
Lower Circuit-
Market Cap₹5,302.07Cr

Aarti Pharmalabs Ltd Key Statistics

P/E Ratio23.24
PEG Ratio5.46
Market Cap₹5,302.07 Cr
P/B Ratio2.43
EPS23.93
Dividend Yield0.69
SectorPharmaceuticals
ROE13.11

Aarti Pharmalabs Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹5,302.07 Cr20.59%0.57₹216 Cr₹1,852 Cr
NA₹887.00 Cr264.92%0.91₹55 Cr₹575 Cr
NA₹2,407.31 Cr159.02%0.62₹43 Cr₹381 Cr
NA₹930.38 Cr681.88%0.65₹23 Cr₹307 Cr
NA₹519.70 Cr31.31%0.56₹13 Cr₹154 Cr

About Aarti Pharmalabs Ltd

Aarti Pharmachem Limited was incorporated as a Public Limited Company in 2019. The Company is engaged in manufacturer of Active Pharmaceutical Ingredients API Pharmaceutical Intermediates New Chemical Entities NCE and Xanthine Derivatives situated in India.In 2001 the Company commissioned first API manufacturing Unit in Dombivali Unit 1 and started Xanthine Unit further it commissioned first API manufacturing Unit 4 in Tarapur for Regulated Markets in 2005 commissioned Caffeine production at Unit 5 with a capacity of 100 Metric Tonnes MT per month in 2016. It expanded block for CSD Vapi and API Tarapur units in 2022.The Scheme of Arrangement for the demerger of Pharma Business Undertaking from Aarti Industries Limited into its wholly owned subsidiary Aarti Pharmalabs Limited was effective on October 17 2022 and operational from July 1 2021. Pursuant to the said Demerger Scheme Aarti Industries Limited hived off its Pharmaceutical Division into a separate entity Aarti Pharmalabs Limited and accordingly all the assets and liabilities pertaining to the Pharma Business Undertaking got transferred and vested into the Company effective from the above said Date.Thereafter the Company in 2023 commercialised Block V at Tarapur Unit 4. Again it enhanced Xanthine capacity to 5000 TPA in 2023.90626008 Equity Shares of Rs 5/ each got listed effective January 30 2023..

Share Price: ₹585.05 per share as on 24 Dec, 2024 04:01 PM
Market Capitalisation: ₹5,302.07Cr as of today
Revenue: ₹458.03Cr as on September 2024 (Q3 24)
Net Profit: ₹54.62Cr as on September 2024 (Q3 24)
Listing date: 30 Jan, 2023
Chairperson Name: Rashesh C Gogri
OrganisationAarti Pharmalabs Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Aarti Pharmalabs Ltd

  • Aarti Pharmalabs Appoints New Company Secretary - 13 Dec, 2024

    Aarti Pharmalabs Limited has appointed Jeevan Mondkar as Company Secretary and Compliance Officer, effective December 13, 2024. Mondkar brings over 19 years of experience in corporate laws and governance.

Insights on Aarti Pharmalabs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 35.00% to 35.16% in Sep 2024 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, AARTIPHARM stock has moved up by 3.6%

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 4.69% to 4.93% in Sep 2024 quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 7.06% to 7.38% in Sep 2024 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 46.46% to 46.10% in Sep 2024 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 557.71 Cr → 462.51 Cr (in ₹), with an average decrease of 17.1% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 65.25 Cr → 54.62 Cr (in ₹), with an average decrease of 8.3% per quarter

Aarti Pharmalabs Ltd Financials

Value in ₹ crore
DetailsQ'3 23Q'4 23Q'1 24Q'2 24Q'3 24
Revenue₹439.80Cr (-)₹448.69Cr (↑2.02%)₹505.77Cr (↑12.72%)₹555.49Cr (↑9.83%)₹458.03Cr (↓17.54%)
Net Income₹51.80Cr (-)₹52.76Cr (↑1.85%)₹65.25Cr (↑23.67%)₹55.45Cr (↓15.02%)₹54.62Cr (↓1.50%)
Net Profit Margin11.78% (-)11.76% (↓0.17%)12.90% (↑9.69%)9.98% (↓22.64%)11.92% (↑19.44%)
Value in ₹ crore
Details2021202220232024
Total Assets₹0.25Cr (-)₹1,826.83Cr (↑7,30,632.00%)₹1,978.32Cr (↑8.29%)₹2,299.22Cr (↑16.22%)
Total Liabilities₹0.02Cr (-)₹542.56Cr (↑27,12,700.00%)₹539.74Cr (↓0.52%)₹677.76Cr (↑25.57%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow-₹0.02Cr (-)- (↓100.00%)-₹64.84Cr (-)₹215.88Cr (↓432.94%)₹183.69Cr (↓14.91%)

Index Inclusions

BSE Healthcare

₹44,092.04

0.03 (13.51%)

BSE Small-Cap

₹55,023.17

0.37 (205.26%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

Aarti Pharmalabs Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
46.1%
-0.77
Foreign Institutions
7.38%
4.48
Mutual Funds
4.93%
5.09
Retail Investors
35.16%
0.46
Others
6.43%
-5.27

Aarti Pharmalabs Ltd Key Indicators

Details20232024
Earning Per Share (₹)21.3523.93
Details202220232024
Return On Equity %16.6212.6113.11
Details202220232024
Return On Assets %6.699.789.43
Details20232024
Book Value Per Share (₹)171.97193.88

Aarti Pharmalabs Ltd Valuation

Aarti Pharmalabs Ltd in the last 5 years

  • Overview

  • Trends

Lowest (11.23x)

February 2, 2023

Today (23.24x)

December 24, 2024

Industry (56.56x)

December 24, 2024

Highest (28.14x)

August 29, 2024

LowHigh

Aarti Pharmalabs Ltd Earnings and Dividends

  • Aarti Pharmalabs Ltd Earnings Results

    Aarti Pharmalabs Ltd’s net profit jumped 5.44% since last year same period to ₹54.62Cr in the Q2 2024-2025. On a quarterly growth basis, Aarti Pharmalabs Ltd has generated -1.5% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Aarti Pharmalabs Ltd Dividends May,2024

    In the quarter ending March 2024, Aarti Pharmalabs Ltd has declared dividend of ₹1 - translating a dividend yield of 0.51%.

    Read More about Dividends

Aarti Pharmalabs Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

Aarti Pharmalabs Ltd is currently in a Bearish trading position according to technical analysis indicators.

FAQs on Aarti Pharmalabs Ltd

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Aarti Pharmalabs Ltd shares.

Aarti Pharmalabs Ltd (AARTIPHARM) share price today is ₹585.05

Aarti Pharmalabs Ltd is listed on NSE

Aarti Pharmalabs Ltd is listed on BSE

  • Today’s highest price of Aarti Pharmalabs Ltd is ₹589.9.
  • Today’s lowest price of Aarti Pharmalabs Ltd is ₹571.5.

PE Ratio of Aarti Pharmalabs Ltd is 23.24

PE ratio = Aarti Pharmalabs Ltd Market price per share / Aarti Pharmalabs Ltd Earnings per share

Today’s traded volume of Aarti Pharmalabs Ltd(AARTIPHARM) is 96.84K.

Today’s market capitalisation of Aarti Pharmalabs Ltd(AARTIPHARM) is ₹5302.07Cr.

Aarti Pharmalabs Ltd(AARTIPHARMPrice
52 Week High
₹721.7
52 Week Low
₹399.55

Aarti Pharmalabs Ltd(AARTIPHARM) share price is ₹585.05. It is down -18.93% from its 52 Week High price of ₹721.7

Aarti Pharmalabs Ltd(AARTIPHARM) share price is ₹585.05. It is up 46.43% from its 52 Week Low price of ₹399.55

Aarti Pharmalabs Ltd(AARTIPHARMReturns
1 Day Returns
6.4%
1 Month Returns
-7.97%
3 Month Returns
-6.13%
1 Year Returns
15.74%